PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

Status Active, not recruiting

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy of PG2 concurrent with concurrent chemoradiation therapy (CCRT) for relieving fatigue among locally advanced esophageal cancer patients who are under preoperative chemoradiation therapy at curative setting. This study will be designed to compare the fatigue status between two study arms patients under CCRT. The secondary objective is to assess the efficacy of PG2 to improve the quality of life of patient during CCRT. Also, the investigators try to determine the effect of PG2 on tumor response post CCRT, disease free survival (DFS) and overall survival (OS) of patients by comparing the above outcome between the two study arms. The mechanism of immunomodulatory of PG2 and tumor response, DFS and OS for patients with esophageal cancer treated with preoperative CCRT concurrent with or without PG2 will be investigated in add-on study.

Clinical Trial Description

It's randomized, open-label study. Locally advanced esophageal cancer patients who give consent to participate in this study and meet all other inclusion and exclusion criteria will be eligible to enroll into this study. The eligible patients will be randomized into one of two study arms: 1) the CCRT- PG2 arm; and 2) the CCRT alone arm. All eligible patients will receive the standard preoperative CCRT during study period and standard surgery 6 weeks after completion of radiation therapy. The primary objective of this study is to evaluate the efficacy of PG2 concurrent with CCRT for relieving fatigue. Patient's fatigue status will be measured by the BFI-T. The secondary objective is to assess the efficacy of PG2 to improve the quality of life of patient during CCRT. Patients' quality of life will be assessed by the Functional Assessment of Cancer Therapy- General (FACT-G7 v.4). Patients' appetite will be assessed by VAS appetite score. The effect of PG2 on tumor response post CCRT, DFS and OS of patients will also be evaluated. Peripheral blood samples and tumor biopsy samples will be collected from all subjects at screening period, during CCRT and post CCRT period to perform Immune biomarker assessment in the add-on study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03611712
Study type	Interventional
Source	PhytoHealth Corporation
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	February 19, 2019
Completion date	February 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01952184` - Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.	N/A
Completed	`NCT00993343` - Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation	Phase 3
Recruiting	`NCT04808466` - Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Not yet recruiting	`NCT04845490` - Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy	Phase 2
Recruiting	`NCT03291275` - Survival Outcomes of Uterine Malignancies in Chinese Population	N/A
Recruiting	`NCT05720858` - Telerehabilitation in Survival Breast Cancer Patients	N/A
Completed	`NCT03351920` - Ventilation's Parameters Applied in Emergency Medicine. A Prospective Observational Study
Not yet recruiting	`NCT06147180` - Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy
Recruiting	`NCT04472403` - Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
Recruiting	`NCT03739944` - Different Surgical Approaches in Patients of Early-stage Cervical Cancer	Phase 3
Not yet recruiting	`NCT02960061` - Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer	Phase 3
Recruiting	`NCT03738969` - Longitudinal Study of Different Surgical Approaches in Chinese Patients of Uterine Cervical Cancer
Completed	`NCT03134807` - The Very Old Intensive Care Patient: A Multinational Prospective Observation Study
Completed	`NCT03084809` - Chemotherapy Combined With CIK Treating Colon Cancer	Phase 4
Completed	`NCT03642041` - Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients
Recruiting	`NCT04351308` - Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma	Phase 2
Recruiting	`NCT03920033` - Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy	N/A
Recruiting	`NCT05540119` - Swedish Oesophago-Gastric Study
Completed	`NCT04519450` - Ultrasound of Accessory Respiratory Muscles
Active, not recruiting	`NCT01835821` - Clinical Study of Porcelain-fused and IPS e.Max CAD Crowns	N/A